Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

High-risk endometrial cancer (EC) is an aggressive disease for which new therapeutic options are needed. Aims of this study were to validate the enhanced immune response in highly mutated ECs and to explore immune profiles in other EC subgroups. We evaluated immune infiltration in 116 high-risk ECs...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggink, Florine A., Van Gool, Inge C., Leary, Alexandra, Pollock, Pamela M., Crosbie, Emma J., Mileshkin, Linda, Jordanova, Ekaterina S., Adam, Julien, Freeman-Mills, Luke, Church, David N., Creutzberg, Carien L., De Bruyn, Marco, Nijman, Hans W., Bosse, Tjalling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353925/
https://www.ncbi.nlm.nih.gov/pubmed/28344870
http://dx.doi.org/10.1080/2162402X.2016.1264565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353925/
https://www.ncbi.nlm.nih.gov/pubmed/28344870
http://dx.doi.org/10.1080/2162402X.2016.1264565

Ejemplares similares